Sebastian Regnery
Overview
Explore the profile of Sebastian Regnery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
558
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regnery S, Katsigiannopulos E, Lau H, Hoegen-Sassmannshausen P, Weykamp F, Renkamp C, et al.
Clin Transl Radiat Oncol
. 2025 Jan;
51():100899.
PMID: 39790128
Purpose: To use imaging data from stereotactic MR-guided online adaptive radiotherapy (SMART) of ultracentral lung tumors (ULT) for development of a safe non-adaptive approach towards stereotactic body radiotherapy (SBRT) of...
2.
Bauer L, Paul A, Regnery S, Deng M, Ellerbrock M, Mielke T, et al.
Front Oncol
. 2024 Dec;
14:1437412.
PMID: 39650062
Introduction: Due to the rarity of mucosal melanomas, few recent studies can be found investigating the success and side effects of therapy for this entity with large numbers of patients....
3.
Deng M, Rauh S, Anil G, Lischalk J, Hahnemann L, Eichkorn T, et al.
Neurooncol Adv
. 2024 Oct;
6(1):vdae160.
PMID: 39434923
Background: Primary optic nerve sheath meningiomas (ONSMs) represent a group of benign tumors originating from the optic nerve sheath, typically causing painless, gradual onset monocular visual loss, which can result...
4.
Janke F, Stritzke F, Dvornikovich K, Franke H, Angeles A, Riediger A, et al.
Int J Cancer
. 2024 Aug;
156(4):853-864.
PMID: 39212345
Local recurrence after radiotherapy is common in locally advanced head and neck cancer (HNC) patients. Re-irradiation can improve local disease control, but disease progression remains frequent. Hence, predictive biomarkers are...
5.
Hoegen-Sassmannshausen P, Jessen I, Buchele C, Schluter F, Rippke C, Renkamp C, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927978
(1) Background: Recent publications foster stereotactic body radiotherapy (SBRT) in patients with adrenal oligometastases or oligoprogression. However, local control (LC) after non-adaptive SBRT shows the potential for improvement. Online adaptive...
6.
Buchele C, Renkamp C, Regnery S, Behnisch R, Rippke C, Schluter F, et al.
Radiat Oncol
. 2024 Jun;
19(1):80.
PMID: 38918828
Introduction: Magnetic resonance guided radiotherapy (MRgRT) allows daily adaptation of treatment plans to compensate for positional changes of target volumes and organs at risk (OARs). However, current adaptation times are...
7.
Deng M, da Silva A, Goller P, Konig L, Schafer H, Maire C, et al.
BMC Cancer
. 2024 Apr;
24(1):449.
PMID: 38605332
Background: While surgical resection remains the primary treatment approach for symptomatic or growing meningiomas, radiotherapy represents an auspicious alternative in patients with meningiomas not safely amenable to surgery. Biopsies are...
8.
Fink C, Buchele C, Baumann L, Liermann J, Hoegen P, Ristau J, et al.
Front Oncol
. 2024 Mar;
14:1308406.
PMID: 38425342
Background: Apart from superior soft tissue contrast, MR-guided stereotactic body radiation therapy (SBRT) offers the chance for daily online plan adaptation. This study reports on the comparison of dose parameters...
9.
Eichkorn T, Lischalk J, Schwarz R, Bauer L, Deng M, Regnery S, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jan;
118(5):1192-1205.
PMID: 38237810
Purpose: Radiation-induced cerebral contrast enhancements (RICE) are frequent after photon and particularly proton radiation therapy and are associated with a significant risk for neurologic morbidity. Nevertheless, risk factors are poorly...
10.
Schunn F, El Shafie R, Kronsteiner D, Sauer L, Kudak A, Bougatf N, et al.
Strahlenther Onkol
. 2023 Nov;
200(6):475-486.
PMID: 37947806
Background: Mobile health (mhealth) is gaining interest, with mobile devices and apps being ever more available among medical facilities and patients. However, in the field of radiation oncology, the medical...